Genital Herpes Tests: When Can Results Be Misleading?

✓ Medically reviewed | Published: | Evidence level: 1A
Recent scrutiny of online herpes remedies highlights another patient-safety issue: establishing an accurate diagnosis. Some herpes blood tests produce false-positive results, making appropriate test selection and confirmation essential before drawing conclusions.
📅 Published:
✓ Reviewed by iMedic Medical Editorial Team
📄 Public Health

Quick Facts

Virus Types
HSV-1 and HSV-2
Preferred Sore Test
PCR or another NAAT
Blood Test Limitation
False positives can occur

Why can a herpes blood test give a false-positive result?

Quick answer: Some HSV-2 antibody tests produce misleading positive results, particularly near the test's cutoff and in people with a low likelihood of infection.

The FDA's October 1 warning letter to Amazon about unapproved genital herpes products emphasized that effective treatment requires professional diagnosis and supervision. For consumers, that raises a related practical issue: understanding what a herpes test actually establishes. A product advertisement, symptom checklist, or isolated laboratory result cannot provide the same assessment as a clinical evaluation. [FDA warning letter](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-736006-10012026).

The FDA addressed testing accuracy separately in a December 2023 safety communication. It warned that HSV-2 blood tests can incorrectly indicate infection, with particular concern about results close to the positive threshold and testing people whose likelihood of infection is low. The agency recommends explaining these limitations before testing and confirming reactive results according to the test's instructions and professional guidance. Confirmation may involve a different method, such as Biokit or Western blot. An initial result therefore needs interpretation alongside symptoms, exposure history, and the specific assay used. [FDA testing safety communication](https://www.fda.gov/medical-devices/letters-health-care-providers/hsv-2-tests-genital-herpes-can-produce-false-reactive-results-letter-clinical-laboratory-staff-and).

Which herpes test is most useful when genital sores appear?

Quick answer: A swab of an active sore tested by PCR or another nucleic acid amplification test is generally the most sensitive approach.

When a person has genital blisters or ulcers, clinicians can collect material directly from a lesion and test it for herpes simplex virus. PCR is one type of nucleic acid amplification test, or NAAT, which detects viral genetic material. Identifying HSV-1 or HSV-2 also helps inform counseling because their patterns of recurrence differ. A negative swab does not always exclude herpes, especially when a lesion is older or viral shedding is intermittent. [CDC herpes diagnostic guidance](https://www.cdc.gov/std/treatment-guidelines/herpes.htm).

Assessment also needs to consider other causes. The CDC cautions that medical history and appearance alone can misidentify genital ulcers; herpes and syphilis can even occur together. Evaluation may therefore include syphilis and HIV testing as well as herpes testing. When a clinician suspects a first episode of genital herpes, treatment may begin while results are pending because prompt therapy matters. Seeking care while sores are present creates an opportunity to obtain an informative sample and address symptoms without unnecessary delay. [CDC genital ulcer guidance](https://www.cdc.gov/std/treatment-guidelines/genital-ulcers.htm).

Should people without symptoms get a herpes blood test?

Quick answer: Routine screening is generally discouraged for people without a history or symptoms of genital herpes, while individual circumstances can justify testing.

In its February 2023 recommendation, the U.S. Preventive Services Task Force advised against routine herpes blood screening in adolescents and adults without a known history, signs, or symptoms, including during pregnancy. Its evidence assessment found that the harms of population screening outweigh the benefits. False-positive diagnoses can cause emotional distress, disrupt relationships, and lead to unnecessary treatment. This recommendation concerns routine screening; people seeking evaluation for suggestive symptoms, and those with HIV or other immunosuppressive conditions, require a different assessment. [USPSTF screening recommendation](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/genital-herpes-serologic-screening).

The CDC identifies circumstances in which blood testing may help, including having a partner with genital herpes or having symptoms that need clarification. Timing matters because tests may not detect a recently acquired infection immediately. Patients can ask which test is being ordered, whether a positive result will need confirmation, and whether follow-up testing could be necessary. They should also check which infections an STI panel includes: a request to test for everything does not guarantee that herpes testing was performed. [CDC patient testing guidance](https://www.cdc.gov/herpes/testing/index.html).

Frequently Asked Questions

False-positive results are possible. A clinician should review the specific test and result and arrange confirmation when indicated, particularly for a low-positive result.

No. HSV-1 antibodies do not identify the infection's location. Testing material from a genital lesion can establish whether HSV-1 is present at that site.

Yes. Antibodies take time to become detectable. A clinician may recommend later testing based on the exposure date, symptoms, and test used.

No. Test selection varies. Ask the clinician or laboratory which infections were tested and whether any result needs follow-up.

Yes, for people without a known history, signs, or symptoms of genital herpes. New symptoms or a partner with herpes warrant an individual discussion with the maternity care team.

References

  1. U.S. Food and Drug Administration. [Warning letter to Amazon.com, Inc., reference 736006](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazoncom-inc-736006-10012026). October 1, 2026.
  2. U.S. Food and Drug Administration. [Safety communication on false-positive HSV-2 blood tests](https://www.fda.gov/medical-devices/letters-health-care-providers/hsv-2-tests-genital-herpes-can-produce-false-reactive-results-letter-clinical-laboratory-staff-and). December 27, 2023.
  3. Centers for Disease Control and Prevention. [Genital Herpes: STI Treatment Guidelines](https://www.cdc.gov/std/treatment-guidelines/herpes.htm). 2021.
  4. Centers for Disease Control and Prevention. [Diseases Characterized by Genital, Anal, or Perianal Ulcers](https://www.cdc.gov/std/treatment-guidelines/genital-ulcers.htm). 2021.
  5. U.S. Preventive Services Task Force. [Genital Herpes Infection: Serologic Screening](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/genital-herpes-serologic-screening). February 14, 2023.
  6. Centers for Disease Control and Prevention. [Screening for Genital Herpes](https://www.cdc.gov/herpes/testing/index.html). February 20, 2024.